NEWYou can now listen to Fox News articles! With new agreements from President Donald Trump promising lower prices on popular weight-loss drugs, the use of GLP-1 medications such as Ozempic and Mounjaro could soon surge even higher — a trend already spreading unevenly across the U.S., with some states seeing greater uptick than others. Based…
NEWYou can now listen to Fox News articles! With new agreements from President Donald Trump promising lower prices on popular weight-loss drugs, the use of GLP-1 medications such as Ozempic and Mounjaro could soon surge even higher — a trend already spreading unevenly across the U.S., with some states seeing greater uptick than others. Based…
When it comes to fitness, both Yoga and Zumba have their loyal followers. While Yoga focuses on mindfulness, flexibility, and inner balance, Zumba is all about high-energy dance moves that make exercise fun and fast-paced. But when your main goal is weight loss and calorie burn, which one actually helps you burn more calories? Let’s…
Processed or ultra-processed foods often contain refined carbs, added sugars, and artificial fats that disrupt metabolism. A 2019 landmark study published in Cell Metabolism, which is a cell press journal, found that people who consumed ultra-processed diets ate about 500 extra calories per day and gained weight, compared to those eating unprocessed foods, even when…
NEWYou can now listen to Fox News articles! For decades, BMI (body mass index) has been the go-to number doctors use to decide whether someone is underweight, “normal,” overweight or obese. But new global research suggests it’s possible to have a normal BMI, look thin in clothes and still meet the medical definition of obesity….
NEWYou can now listen to Fox News articles! Popular drugs credited with shrinking waistlines and controlling blood sugar may also take the edge off alcohol’s buzz, according to a new study. Researchers at Virginia Tech’s Fralin Biomedical Research Institute analyzed how 20 adults with obesity — half of whom had been taking GLP-1 receptor agonists…
